Managing generic competition and patent strategies in the pharmaceutical industry

Journal of Intellectual Property Law and Practice

Volumn 3, Issue 4, 2008, Pages 226-235

  Whitehead, Brian ^a   Jackson, Stuart ^a   Kempner, Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78449277020     PISSN: None     EISSN: 17471540     Source Type: Journal    
DOI: 10.1093/jiplp/jpn013     Document Type: Review

References (36)

1. See, for example, Ranbaxy v Warner-Lambert [2006] EWCA Civ 876
2. Case C-431/04, ECJ judgment, 4 May 2006.
3. BASF v SmithKline Beecham [2002] EWHC 1373. The authors acted for BASF in this case.
4. [2007] EWHC 1538.
5. Synthon v SmithKline Beecham 2006 RPC 10.
6. [2007] EWHC 1040.
7. 1997 RPC 1.
8. [2005] EWHC 2141. The authors acted for Teva in this case.
9. [2005] EWCA Civ 137.
10. [2006] EWHC 1123.
11. [2005] EWHC 2532.
12. [2004] EWHC 477.
13. Merrell Dow v Norton 1996 RPC 76.
14. [1967] RPC 479.
15. [1974] RPC 241.
16. [2005] EWCA Civ 177.
17. Schering Plough v Norbrook [2005] EWHC 2532;
18. Novartis v Ivax [2006] EWHC 2506;
19. Generics v Lundbeck [2007] EWHC 1040;
20. Actavis v Merck [2007] EWHC 1311.
21. Ivax v Chugai [2006] EWHC 756;
22. Conor v Angiotech [2007] EWCA Civ 5;
23. Teva v Merrell [2007] EWHC 2276.
24. G 5/83, EISAI/Second Medical Indication.
25. Schering's Applications [1985] IPD 8032 (Patents Court).
26. [2001] RPC 1.
27. T 1020/03, Genentech/Method of Administration of IGF-I.
28. [2007] EWHC 1311.
29. [2007] EWHC 2276.
30. See, for example, Pfizer v Eurofood [2001] FSR 3, concerning sales of a drink product 'Viagrene'.
31. [2003] EWHC 5.
32. [2003] EWCA Civ 5.
33. Arrow v Merck [2007] EWHC 1900.
34. BASF AG v SmithKline Beecham plc [2002] EWHC 1373.
35. SmithKline Beecham plc v Apotex Europe Limited [2003] EWHC 2939.
36. SmithKline Beecham plc & Beecham Group v Apotex Corporation.